Which ASM? I'll listen again. Dr Lebby became CEO in 2017 yet the 10k for the 2017 year still says to expect commercialization in 2018, and that was filed nearly a year after he had become CEO. Maybe it was an oversight, and they DID remove the language the next year, so it was a step in the right direction..
but now we are hearing of commercialization hopes but the supposed ACTUAL commercialization announced so far hasn't produced anything:
We expect that we will incur approximately $475,000 of expenditures over the next 12 months. Our cash requirements are expected to increase at a rate consistent with the Company’s path to revenue growth as we expand our activities and operations with the objective of commercializing our electro-optic polymer technology during 2018.